Gene Techno Science Co Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Gene Techno Science Co Ltd with three other
companies in this sector in Japan:
Human Metabolome Technologies Inc
(2019
sales of 791.51 million Japanese Yen [US$7.27 million]
of which 100%
was Metabolome analysis business),
SanBio Co Ltd
(741.61 million Japanese Yen [US$6.82 million]
of which 100%
was Allogeneic cell transplantation), and
PhoenixBio Co Ltd
(1.23 billion Japanese Yen [US$11.29 million]
).
Sales Analysis.
Gene Techno Science Co Ltd reported sales of ¥1.02 billion (US$9.39 million)
for the
fiscal
year ending
March of 2019.
This
represents
a
decrease of 3.6%
versus 2018, when the company's sales were ¥1.06 billion.